Cytalon 500mg Injection About
Cytalon 500mg Injection emerges as a venerable solution for acute myeloid leukemia (AML) therapy, carefully formulated with the potent and redoubtable cytarabine. This crackerjack offer presents a colorless, ready-to-use solution designed specifically for intravenous, intrathecal, or subcutaneous administration. Each single-dose vial contains 500 mg/5 mL, ensuring precise delivery and highlighted efficacy. Originating from India, this prescription-only product adheres to strict pharmaceutical standards, making it a compelling deal for exporters, manufacturers, and suppliers seeking premium oncology solutions. Store below 25C and consult dosage guidelines for optimum results.
Application and Specific Usage of Cytalon 500mg Injection
Cytalon 500mg Injection is highlighted for its plant-based application in modern oncology treatment centers. Used as a targeted anticancer chemotherapy agent, this redoubtable injectable delivers cytarabine directly for the management of acute myeloid leukemia (AML) in adults. The ready-to-use and single dose vial ensures streamlined administration, providing clinical precision with each application. Venerable for both initial induction and consolidation phases, Cytalon is specifically recommended under the supervision of a healthcare professional.
Packaging, Delivery, and Valuation Details for Cytalon 500mg Injection
Cytalon 500mg Injection is delivered in robust vial packaging, with one vial per box as per the packaging norm. Available for both domestic and international markets, it is duly valued for its secure packaging and reliable shipment. Payment terms include flexible options tailored for bulk orders. The FOB port is typically designated in India, ensuring prompt shipping arrangements. Each batch undergoes stringent valuation to maintain quality assurance throughout the entire distribution process.
FAQ's of Cytalon 500mg Injection:
Q: How should Cytalon 500mg Injection be administered for AML treatment?
A: Cytalon 500mg Injection is administered via intravenous, intrathecal, or subcutaneous routes, according to the prescribed regimen by a qualified healthcare provider for treating acute myeloid leukemia (AML).
Q: What is the primary benefit of using Cytalon 500mg Injection?
A: The primary benefit is its potent efficacy in managing acute myeloid leukemia (AML), aided by a precise 500 mg dose of cytarabine in a ready-to-use, single-dose vial format, ensuring reliable delivery.
Q: When is Cytalon 500mg Injection indicated?
A: Cytalon 500mg Injection is indicated for use in adults diagnosed with acute myeloid leukemia (AML), and it should be used as part of a supervised anticancer chemotherapy protocol.
Q: Where is Cytalon 500mg Injection manufactured and exported from?
A: Cytalon 500mg Injection is manufactured and exported from India, meeting international standards for oncology products.
Q: What are the recommended storage conditions for Cytalon 500mg Injection?
A: The injection should be stored below 25C, and users should always check the expiry date on the pack before administration.
Q: How is the payment process handled for bulk orders of Cytalon 500mg Injection?
A: Payment terms for bulk orders are flexible and can be tailored according to client requirements, with FOB port options typically based in India.